InvestorsHub Logo
Followers 3
Posts 251
Boards Moderated 0
Alias Born 04/23/2013

Re: None

Tuesday, 03/19/2019 12:31:52 PM

Tuesday, March 19, 2019 12:31:52 PM

Post# of 64376
For over a year, I've warned that Nyloxin lacks the credentials to be sold in the US.

Eg: Nyloxin failed to meet the government standards for an opioid replacement: Double-blind, placebo-controlled, published and peer-reviewed studies.

Proof: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=143940654

In another post, I even stated, I've been through it myself.

Those who took me seriously are not unhappy today.

Thinking